People · Operator
Named in public records as an officer, director or promoter · active 2019–2025 · Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| PreciseDx, Inc. | — | Other Health Care | Series B | $32.0M | $55.7M | 2024 |
| Tacitus Therapeutics Inc. | — | Pharmaceuticals | Series A | $5.0M | $154.9M | 2019 |
| Verici DX plc | — | Other Health Care | Seed | $2.7M | $58.2M | 2020 |
Erik Lium at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Erik Lium on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carter Cliff | 1 | 4 |
| Jeffrey Kennedy | 1 | 3 |
| James McCullough | 1 | 3 |
| Sara Barrington | 1 | 3 |
| Wayne Brinster | 1 | 2 |
| Michael Hennessy Jr. | 1 | 2 |
| Paul Roma | 1 | 2 |
| Edward Joseph Sitar | 1 | 1 |
| Eric Converse | 1 | 1 |
| Molly Harper | 1 | 1 |
| Barbara Murphy | 1 | 1 |
| Julian Baines | 1 | 1 |
| Ian Carruthers | 1 | 1 |
| Salim Hamir | 1 | 1 |
| Westley Dupray | 1 | 1 |
| Thomas Novak | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.